Literature DB >> 18674744

Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis.

Mario C Rico1, Joanne M Manns, Jeffrey B Driban, Audrey B Uknis, Satya P Kunapuli, Raul A Dela Cadena.   

Abstract

Thrombospondin-1 (TSP1/THBS1) plays a major role in the pathophysiology of rheumatoid arthritis (RA); however, its interface with the cytokine network involved in RA has not been delineated. Correlations were performed between plasma levels of TSP1 and selected cytokines from blood samples collected from 20 patients affected by RA and 13 healthy donors (control). Plasma levels of TSP1 and tissue growth factor beta (TGFbeta) were determined by standard enzyme-linked immunosorbent assay, and cytokines were measured by protein profiling rolling-circle amplification (RCA). TSP1 circulating levels in plasma were found significantly increased in the RA patients when compared with control individuals (P = 0.039). The plasma levels of TGFbeta were also increased in the RA patients, which indicates a statistical trend. Cytokine levels of interleukin (IL)-4, IL-5, IL-12, chemokine CXC 10 (CXCL10/IP10), and chemokine CC 4 (CCL4)/MIP1beta were significantly increased in the RA patients when compared with the control group. In summary, this study demonstrates increased plasma levels of TSP1, which correlated with increased levels of proinflammatory cytokines in plasma of RA patients. More detailed research is required to explore the cytokine imprint yielded by this study and its interface with TSP1 and TGFbeta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674744      PMCID: PMC2529228          DOI: 10.1016/j.trsl.2008.06.002

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  16 in total

1.  Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients.

Authors:  M Janabi; S Yamashita; K Hirano; N Sakai; H Hiraoka; K Matsumoto; Z Zhang; S Nozaki; Y Matsuzawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

Review 2.  The structural and functional properties of thrombospondin.

Authors:  J Lawler
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

Review 3.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

4.  Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant-induced arthritis.

Authors:  A E Koch; Z Szekanecz; J Friedman; G K Haines; C B Langman; N P Bouck
Journal:  Clin Immunol Immunopathol       Date:  1998-02

5.  Multiplexed protein profiling on microarrays by rolling-circle amplification.

Authors:  Barry Schweitzer; Scott Roberts; Brian Grimwade; Weiping Shao; Minjuan Wang; Qin Fu; Quiping Shu; Isabelle Laroche; Zhimin Zhou; Velizar T Tchernev; Jason Christiansen; Mark Velleca; Stephen F Kingsmore
Journal:  Nat Biotechnol       Date:  2002-04       Impact factor: 54.908

6.  Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-beta1 in synovial fibroblasts from rheumatoid arthritis and normal individuals.

Authors:  H Cheon; S-J Yu; D H Yoo; I J Chae; G G Song; J Sohn
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

7.  Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium.

Authors:  I Gotis-Graham; P J Hogg; H P McNeil
Journal:  Arthritis Rheum       Date:  1997-10

8.  A peptide from thrombospondin 1 modulates experimental erosive arthritis by regulating connective tissue growth factor.

Authors:  Joanne M Manns; Audrey B Uknis; Mario C Rico; Alexis Agelan; Julian Castaneda; Israel Arango; Mary F Barbe; Fayez F Safadi; Steven N Popoff; Raul A DeLa Cadena
Journal:  Arthritis Rheum       Date:  2006-08

9.  Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.

Authors:  S Schultz-Cherry; J E Murphy-Ullrich
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Active and latent forms of transforming growth factor beta activity in synovial effusions.

Authors:  R Fava; N Olsen; J Keski-Oja; H Moses; T Pincus
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  17 in total

1.  Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.

Authors:  Latt Latt Aung; Andrew Brooks; Steven A Greenberg; Michael L Rosenberg; Suhayl Dhib-Jalbut; Konstantin E Balashov
Journal:  J Neuroimmunol       Date:  2012-06-09       Impact factor: 3.478

2.  Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor.

Authors:  Mario C Rico; James J Rough; Joanne M Manns; Fabiola Del Carpio-Cano; Fayez F Safadi; Satya P Kunapuli; Raul A DeLa Cadena
Journal:  Thromb Res       Date:  2011-09-01       Impact factor: 3.944

3.  Thrombospondin-1 (TSP1) contributes to the development of vascular inflammation by regulating monocytic cell motility in mouse models of abdominal aortic aneurysm.

Authors:  Zhenjie Liu; Stephanie Morgan; Jun Ren; Qiwei Wang; Douglas S Annis; Deane F Mosher; Jing Zhang; Christine M Sorenson; Nader Sheibani; Bo Liu
Journal:  Circ Res       Date:  2015-05-04       Impact factor: 17.367

Review 4.  Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-beta signaling.

Authors:  Jason B Wheeler; John S Ikonomidis; Jeffrey A Jones
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouse.

Authors:  Timothy P LaBranche; Cynthia L Hickman-Brecks; Debra M Meyer; Chad E Storer; Michael I Jesson; Kimberly M Shevlin; Fernando A Happa; Ruteja A Barve; David J Weiss; John C Minnerly; Jennifer L Racz; Paul M Allen
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

6.  Myeloid-specific deletion of thrombospondin 1 protects against inflammation and insulin resistance in long-term diet-induced obese male mice.

Authors:  Hasiyet Memetimin; Dong Li; Kaiyuan Tan; Changcheng Zhou; Ying Liang; Yadi Wu; Shuxia Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-23       Impact factor: 4.310

7.  The effects of Kv1.3 and IKCa1 channel inhibition on cytokine production and calcium influx of T lymphocytes in rheumatoid arthritis and ankylosing spondylitis.

Authors:  Gergely Toldi; Luis Munoz; Martin Herrmann; Georg Schett; Attila Balog
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 8.  Role of thrombospondin 1 in liver diseases.

Authors:  Yanzhang Li; Courtney P Turpin; Shuxia Wang
Journal:  Hepatol Res       Date:  2016-08-30       Impact factor: 4.288

Review 9.  Thrombospondin-1 in maladaptive aging responses: a concept whose time has come.

Authors:  Jeffrey S Isenberg; David D Roberts
Journal:  Am J Physiol Cell Physiol       Date:  2020-05-06       Impact factor: 4.249

Review 10.  Location, location, location: how the tissue microenvironment affects inflammation in RA.

Authors:  Christopher D Buckley; Caroline Ospelt; Steffen Gay; Kim S Midwood
Journal:  Nat Rev Rheumatol       Date:  2021-02-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.